27 DEC 2013 Pharmaceuticals European Medicines Agency (EMA) Accepts Otsuka's Marketing Authorisation Application (MAA) for Tolvaptan, an Investigational Compound for Autosomal Dominant Polycystic Kidney Disease (ADPKD)
11 DEC 2013 Pharmaceuticals Lundbeck and Otsuka to Co-Develop a Vaccine, Lu AF20513, Their Third Collaborative Development Project to Tackle Alzheimer's Disease
3 DEC 2013 Corporate Providing Free Health Care to Over 700,000 Afghan Refugees : The 10th Anniversary of the "Otsuka Welfare Clinic"
25 NOV 2013 Pharmaceuticals CHMP Recommends Otsuka's Deltyba™ (delamanid) for EU Approval for Treatment of Multidrug-Resistant Tuberculosis (MDR-TB) in Combination with Optimized Background Regimen (OBR)
25 NOV 2013 Nutraceuticals New From the US, A Smart New Way to Take Vitamin and Mineral Supplements VitaMelts® Dissolve Smoothly Without Water Available at Convenience Stores Throughout Japan From November 25
21 NOV 2013 Pharmaceuticals Otsuka and Lundbeck's Once-Monthly Abilify Maintena® (Aripiprazole) Now Approved in Europe for Maintenance Treatment of Schizophrenia in Adult Patients Stabilized with Oral Aripiprazole
5 NOV 2013 Corporate Otsuka Co-sponsors the Fifth Annual Asan Walking Festival in Itano on November 10
31 OCT 2013 Pharmaceuticals Otsuka Named as Lundbeck's Partner in Japan on Nalmefene for the Reduction of Alcohol Consumption
23 OCT 2013 Nutraceuticals Get the Dietary Fiber That is Missing From Your Diet*1With a Healthy Combination of Cereal Grains Otsuka Launches the New Products "Gerblé Multicereal Chocolate" and "Gerblé Multicereal Apricot"
10 OCT 2013 Pharmaceuticals Lundbeck and Otsuka Initiate Phase III Clinical Trials on Lu AE58054 as a New Add-On Treatment for Alzheimer's Disease
1 OCT 2013 Pharmaceuticals Otsuka Pharmaceutical Receives the 2013 Good Design Award for the Antiplatelet Drug "Pletaal® OD Tablets"
20 SEP 2013 Pharmaceuticals Otsuka And Lundbeck Receive Postive Chmp Opinion In Europe For Abilify Maintena™, A Once-Monthly Injectable For Schizophrenia
18 SEP 2013 Nutraceuticals Two New Flavors of SoyCarat Nori & Natto and Olive Oil & Garlic Flavors Debut October 2
17 SEP 2013 Pharmaceuticals Vasopressin V2 Receptor Antagonist Samsca®7.5mg Tablets Granted Additional Indication in Japan for the Treatment of Fluid Retention in Patients with Hepatic Cirrhosis
5 SEP 2013 Nutraceuticals UL•OS Line of Men's Skin Care Marks 5th Anniversary Now Effective in Minimizing the Appearance of Fine Lines and Wrinkles Caused by Dryness
30 AUG 2013 Pharmaceuticals Otsuka Receives Complete Response Letter From U.S. Food And Drug Administration For Tolvaptan For Use In Patients With Autosomal Dominant Polycystic Kidney Disease
28 AUG 2013 Pharmaceuticals Japan's First Dry Syrup Formulation of an Anti-epileptic Drug for the Treatment of Partial-onset Seizures, E Keppra® Dry Syrup 50%, to Be Launched on August 29
19 AUG 2013 Nutraceuticals On September 1, Otsuka Launches "Omugi Seikatsu," a Healthy Breakfast Food With Barley Beta-Glucans
6 AUG 2013 Pharmaceuticals U.S. Food and Drug Administration's Cardiovascular and Renal Drugs Advisory Committee Recommends Against Approval of Otsuka Pharmaceutical's Tolvaptan for Use in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
6 AUG 2013 Pharmaceuticals Fingraph®, a fingertip blood sampler that conveniently measures sodium and potassium electrolyes in just one minute, debuts in Japan on August 6
1 AUG 2013 Corporate Come Check Out Our Brand New English Site! Global Website for Global Company Launches on Aug 1, 2013 http://www.otsuka.co.jp/en
17 JUL 2013 Pharmaceuticals Phase II clinical data show statistically significant improvement for Lu AE58054 as add-on to donepezil, versus donepezil alone, on cognitive symptoms of Alzheimer's disease*1 Lundbeck and Otsuka present data at Alzheimer’s Association International Conference 2013
10 JUL 2013 Nutraceuticals A Heat Wave Is Coming - Protect Yourself From Heat Stroke Otsuka's New "Heat Stroke Prevention Information" Service Launches July 8 Receive Automatic Updates on a "Heat Index" Indicating Your Heat Stroke Risk Level
10 JUL 2013 Pharmaceuticals Otsuka Europe Development and Commercialisation Ltd., a New Company for the Development of Pharmaceuticals Opens in the UK
28 JUN 2013 Pharmaceuticals Two New Formulations of E Keppra® Developed Dry Syrup Obtains Approval; Application Filed for Injectable Formulation Address various needs of patients with epilepsy from 4 years of age and contribute to improvement of compliance with medication
14 JUN 2013 Pharmaceuticals A New Choice of Therapy for the Treatment of Depression:ABILIFY® Granted Additional Approval as Adjunctive Therapy for the Treatment of Depression in Japan
10 JUN 2013 Nutraceuticals The No.1 pharmacist-recommended supplement*1「Nature Made」The First Supplement Facility was Built in Alabama*2.Production Capacity Increases 40% by 2014
7 JUN 2013 Corporate Otsuka has been selected by METI as a model enterprise for business continuity management
3 JUN 2013 Pharmaceuticals Otsuka Pharmaceutical Submits New Drug Application in Japan for Tolvaptan for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
3 JUN 2013 Pharmaceuticals Vasopressin V2 Receptor Antagonist Samsca® 7.5mg Tablets To Be Launched in Japan on June 4 - Additional Choice of Dose for the Treatment of Volume Overload in Patients with Heart Failure
31 MAY 2013 Pharmaceuticals Antiepileptic Drug E Keppra® Tablet Approved in Japan for Pediatric Epilepsy (Partial-Onset Seizures)
22 MAY 2013 Pharmaceuticals Study Shows Effects of Treatment with ABILIFY MAINTENA™ (Aripiprazole) on Psychiatric Hospitalization Rates for Patients with Schizophrenia
9 MAY 2013 Pharmaceuticals Acucela and Otsuka Pharmaceutical Announce Phase IIa Clinical Results of Emixustat Hydrochloride (ACU-4429) in Patients with Geographic Atrophy (GA) Associated with Dry Age-related Macular Degeneration (AMD) at ARVO 2013 Annual Meeting
30 APR 2013 Pharmaceuticals Otsuka Pharmaceutical's 44-member Employee Dance Group "Otsuka-Ren" Presented Traditional "Awa-Odori" of Tokushima, Where the Company Originates From, At Copenhagen Sakura Festival Held in Denmark
17 APR 2013 Pharmaceuticals "Epi Diary" - An Epilepsy Diary Application for iOS A New Communication Tool for Patients with Epilepsy and their Physicians Now Available at https://itunes.apple.com/app/epi-diary/id616736809?Is=1&mt=8
12 APR 2013 Pharmaceuticals Otsuka's New Drug Application For Tolvaptan, An Investigational Compound For Autosomal Dominant Polycystic Kidney Disease (ADPKD), Accepted For Review By The US Food And Drug Administration (FDA)
4 APR 2013 Nutraceuticals New Version of POCARI SWEAT Low calorie beverage with subtle sweetness, refreshing after-taste POCARI SWEAT ION WATER Debuts April 8, 2013
1 APR 2013 Corporate Like Having Everything At Your Fingertips? Then Check This Out! Otsuka Pharmaceutical Announces A Revamped Website April 1, 2013 http://www.otsuka.co.jp/
27 MAR 2013 Pharmaceuticals Otsuka's Novel Treatment for Multidrug-Resistant Tuberculosis, Delamanid, Submitted For Regulatory Approval in Japan -- Half Century Since Last Drug Was Approved in Japan for Tuberculosis
26 MAR 2013 Pharmaceuticals Lundbeck and Otsuka Further Expand Alliance and Enter Into Collaboration For the Development and Commercialization of Lu AE58054 In Development For Alzheimer's Disease
25 MAR 2013 Pharmaceuticals Otsuka Obtains Marketing Approval in Japan for Onglyza® Tablets to Treat Type 2 Diabetes; Transferred Rights to Kyowa Hakko Kirin
14 MAR 2013 Nutraceuticals "Weight Management with Chocolate" White Chocolate and Orange Chocolate Gerlinéa Meal Replacement Bars Debut on March 18
13 MAR 2013 Nutraceuticals The Healthy Benefits of Whole Soy Flavored with Crunchy Peanuts SOYJOY Peanuts Debuts April 24
7 MAR 2013 Pharmaceuticals Otsuka Advancing Rapidly in Central Nervous System Disorders; Expanding Its Existing Collaboration with Lundbeck
1 MAR 2013 Pharmaceuticals FDA Approves Once-Monthly ABILIFY MAINTENA™ (Aripiprazole) For Extended-Release Injectable Suspension for the Treatment of Schizophrenia
22 FEB 2013 Pharmaceuticals The First Transdermal Dopamin Agonist in Japan Neupro® Patch, For Both Parkinson's Disease and Restless Legs Syndrome, To Be Launched on February 26
22 FEB 2013 Pharmaceuticals L-Cartin® FF oral solution 10% and L-Cartin® FF injection 1000mg Two New Drug Forms for Carnitine Deficiency To Be Launched on February 26
20 FEB 2013 Nutraceuticals Otsuka Pharmaceutical Contributes to the Success and Development of the Tokyo Marathon as a Total Health Care Company Supporting Safe Running and Encouraging Runners to Complete the Full Distance with Amino Acids, Fluids and Electrolytes
8 FEB 2013 Pharmaceuticals 7.5mg Tablets Additionally Approved - Samsca®, Vasopressin V2 Receptor Antagonist
6 FEB 2013 Pharmaceuticals The European Medicines Agency (EMA) Approves Aripiprazole (ABILIFY®) for the Treatment of Moderate to Severe Manic Episodes in Bipolar I Disorder in Adolescents.
28 JAN 2013 Nutraceuticals UL・OS Line of Men's Skincare Launches New SPF 50 & SPF 25 Sunscreens Applies Smoothly, Leaves No White Residue
11 JAN 2013 Pharmaceuticals Otsuka Pharmaceutical Files for Application of New Dry Powder Inhaler Product from the Meptin Brand
9 JAN 2013 Nutraceuticals French subsidiary Nutrition & Santé acquires gluten-free nutrition company from Lactalis Group